SIM
ABBV icon

SWP Investment Management’s AbbVie ABBV Stock Holding History

SWP Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.38M Buy
13,423
+500
+4% +$108K 2.33% 15
2026
Q1 		$2.81M Buy
12,923
+250
+2% +$55.5K 2.1% 23
2025
Q4 		$2.9M Buy
12,673
+3,235
+34% +$737K 2.1% 22
2025
Q3 		$2.19M Buy
9,438
+825
+10% +$168K 2.15% 20
2025
Q2 		$1.6M Buy
8,613
+75
+0.9% +$13.9K 1.89% 30
2025
Q1 		$1.79M Buy
+8,538
New +$1.66M 2.23% 12

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

SWP Investment Management's ABBV Position: Q2 2026 in Review

SWP Investment Management increased its AbbVie (ABBV) stake by 3.9% in Q2 2026, buying an estimated $108K and bringing the position to 13,423 shares worth $3.38M. The position accounts for 2.33% of the portfolio, ranked #15.

SWP Investment Management first reported a position in ABBV in Q1 2025 and has held it in 6 quarters since. 4,192 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • SWP Investment Management held 13,423 shares of AbbVie worth $3.38M as of Q2 2026.
  • SWP Investment Management bought 500 AbbVie shares in Q2 2026, an estimated $108K.
  • AbbVie made up 2.33% of SWP Investment Management's portfolio in Q2 2026, its #15 holding.
  • SWP Investment Management first reported a position in AbbVie in Q1 2025 and has held it in 6 quarters since.
  • 4,192 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on SWP Investment Management's 13F filing for Q2 2026, filed 2 Jul 2026.